General Features

Recruitment started in March 2011 and was completed in January 2017. During this period 849 analyzable patients were randomized.

Duration of the study
In November 2019 the median follow-up of 48 month were reached.

Participating centers
Patients were randomized in 39 centers in the Netherlands, Germany, The United Kingdom, Denmark and the United States. All centers have qualified cardiology departments with facilities for ICD implantation and have ample experience with both TV- and S-ICD implantation. Implantations and follow up visits are performed under routine protocols.

Results of the study was presented at HRS2020Science. The presentation is available here. The data are published in The New England Journal of Medicine. Results can also be found here.

The Praetorian trial is registered with (NCT01296022).